The role of alpha-synuclein in neurotransmission and synaptic plasticity

Journal of Chemical Neuroanatomy

Volumn 42, Issue 4, 2011, Pages 242-248

  Cheng, Furong ^a   Vivacqua, Giorgio ^b   Yu, Shun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alpha synuclein; Neuron; Neurotransmission; Synaptic plasticity; Synucleinopathy

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; NEUROTRANSMITTER;

DEGENERATIVE DISEASE; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SYNAPSE VESICLE;

ALPHA-SYNUCLEIN; ANIMALS; HUMANS; NEURODEGENERATIVE DISEASES; NEURONAL PLASTICITY; PROTEIN TRANSPORT; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 80555155665     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2010.12.001     Document Type: Review

References (84)

1. Aarsland D., Andersen K., Larsen J.P., Perry R., Wentzel-Larsen T., Lolk A., Kragh-Sørensen P. The rate of cognitive decline in Parkinson disease. Arch. Neurol. 2004, 61:1906-1911.
2. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
3. Ahn B.H., Rhim H., Kim S.Y., Sung Y.M., Lee M.Y., Choi J.Y., Wolozin B., Chang J.S., Lee Y.H., Kwon T.K., Chung K.C., Yoon S.H., Hahn S.J., Kim M.S., Jo Y.H., Min D.S. alpha-Synuclein interacts with phospholipase D isozymes and inhibits pervanadate-induced phospholipase D activation in human embryonic kidney-293 cells. J. Biol. Chem. 2002, 277:12334-12342.
4. Ahn K.J., Paik S.R., Chung K.C., Kim J. Amino acid sequence motifs and mechanistic features of the membrane translocation of alpha-synuclein. J. Neurochem. 2006, 97:265-279.
5. Albani D., Peverelli E., Rametta R., Batelli S., Veschini L., Negro A., Forloni G. Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70. FASEB J. 2004, 18:1713-1715.
6. Baba M., Nakajo S., Tu P.H., Tomita T., Nakaya K., Lee V.M., Trojanowski J.Q., Iwatsubo T. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol. 1998, 152:879-884.
7. Baptista M.J., O'Farrell C., Daya S., Ahmad R., Miller D.W., Hardy J., Farrer M.J., Cookson M.R. Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. J. Neurochem. 2003, 85:957-968.
8. Bellani S., Sousa V.L., Ronzitti G., Valtorta F., Meldolesi J., Chieregatti E. The regulation of synaptic function by alpha-synuclein. Commun. Integr. Biol. 2010, 3:106-109.
9. Bonini N.M., Giasson B.I. Snaring the function of alpha-synuclein. Cell 2005, 123:359-361.
10. Cabin D.E., Shimazu K., Murphy D., Cole N.B., Gottschalk W., McIlwain K.L., Orrison B., Chen A., Ellis C.E., Paylor R., Lu B., Nussbaum R.L. Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein. J. Neurosci. 2002, 22:8797-8807.
11. Campbell D.G., Hardie D.G., Vulliet P.R. Identification of four phosphorylation sites in the N-terminal region of tyrosine hydroxylase. J. Biol. Chem. 1986, 261(10). 489-10 492.
12. Chandra S., Gallardo G., Fernández-Chacón R., Schlüter O.M., Südhof T.C. Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration. Cell 2005, 123:383-396.
13. Chu Y., Kordower J.H. Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?. Neurobiol. Dis. 2007, 25:134-149.
14. Clayton D.F., George J.M. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. TINS 1998, 21:249-254.
15. Clayton D.F., George J.M. Synucleins in synaptic plasticity and neurodegenerative disorders. J. Neurosci. Res. 1999, 58:120-129.
16. Cockcroft S. Signalling roles of mammalian phospholipase D1 and D2. Cell. Mol. Life Sci. 2001, 58:1674-1687.
17. Crowther R.A., Jakes R., Spillantini M.G., Goedert M. Synthetic filaments assembled from C-terminally truncated alpha-synuclein. FEBS Lett. 1998, 436:309-312.
18. Davidson W.S., Jonas A., Clayton D.F., George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 1998, 273:9443-9449.
19. Dean E.D., Torres G.E., Miller G.W. Alpha-synuclein interacts with VMAT2 to regulate VMAT2 activity. Toxicol. Sci. 2007, 96:45.
20. Dunkley P.R., Bobrovskaya L., Graham M.E., von Nagy-Felsobuki E.I., Dickson P.W. J. Neurochem. 2004, 91:1025-1043.
21. Eiden L.E. The vesicular neurotransmitter transporters: current perspectives and future prospects. FASEB J. 2000, 14:2396-2400.
22. Fernagut P.O., Hutson C.B., Fleming S.M., Tetreaut N.A., Salcedo J., Masliah E., Chesselet M.F. Behavioral and histopathological consequences of paraquat intoxication in mice: effects of alpha-synuclein over-expression. Synapse 2007, 61:991-1001.
23. Fleming S.M., Salcedo J., Fernagut P.O., Rockenstein E., Masliah E., Levine M.S., Chesselet M.F. Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. J. Neurosci. 2004, 24:9434-9440.
24. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M.S., Shen J., Takio K., Iwatsubo T. alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 2002, 4:160-164.
25. Gai W.P., Power J.H., Blumbergs P.C., Blessing W.W. Multiple-system atrophy: a new alpha-synuclein disease?. Lancet 1998, 352:547-548.
26. Giasson B.I., Duda J.E., Murray I.V., Chen Q., Souza J.M., Hurtig H.I., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science 2000, 290:985-989.
27. Goda Y. SNAREs and regulated vesicle exocytosis. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:769-772.
28. George J.M., Jin H., Woods W.S., Clayton D.F. Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 1995, 15:361-372.
29. Graybiel A.M., Pickel V.M., Joh T.H., Reis D.J., Ragsdale C.W. Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:5871-5875.
30. Guo J.T., Chen A.Q., Kong Q., Zhu H., Ma C.M., Qin C. Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells. Cell. Mol. Neurobiol. 2008, 28:35-47.
31. Gureviciene I., Gurevicius K., Tanila H. Role of alpha-synuclein in synaptic glutamate release. Neurobiol. Dis. 2007, 28:83-89.
32. Gureviciene I., Gurevicius K., Tanila H. Aging and alpha-synuclein affect synaptic plasticity in the dentate gyrus. J. Neural Transm. 2009, 116:13-22.
33. Haber S.N. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003, 26:317-330.
34. Han H., Weinreb P.H., Lansbury P.T. The core Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by beta-amyloid: is NAC a common trigger or target in neurodegenerative disease?. Chem. Biol. 1995, 2:163-169.
35. Hartman V.N., Miller M.A., Clayton D.F., Liu W.C., Kroodsma D.E., Brenowitz E.A. Testosterone regulates alpha-synuclein mRNA in the avian song system. Neuroreport 2001, 12:943-946.
36. Haycock J.W. Phosphorylation of tyrosine hydroxylase in situ at serine 8, 19, 31, and 40. J. Biol. Chem. 1990, 265(11). 682-11 691.
37. Iwai A., Yoshimoto M., Masliah E., Saitoh T. Non-Ab component of Alzheimer's disease amyloid (NAC) is amyloidogenic. Biochemistry 1995, 34:10139-10145.
38. Jakes R., Spillantini M.G., Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett. 1994, 345:27-32.
39. Jellinger K.A. A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol. 2008, 116:1-16.
40. Jenco J.M., Rawlingson A., Daniels B., Morris A.J. Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by α- and β-synuclein. Biochemistry 1998, 37:4901-4909.
41. Kanda S., Bishop J.F., Eglitis M.A., Yang Y., Mouradian M.M. Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience 2000, 97:279-284.
42. Kim E.M., Elliot J.J., Hobson P., O'Hare E. Effects of intrahippocampal NAC 61-95 injections on memory in the rat and attenuation with vitamin E. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:945-951.
43. Kim T.D., Paik S.R., Yang C.H. Structural and functional implications of C-terminal regions of alpha-synuclein. Biochemistry 2002, 41:13782-13790.
44. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T.E., Muzyczka N., Mandel R.J., Björklund A. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci. 2002, 22:2780-2791.
45. Larsen K.E., Schmitz Y., Troyer M.D., Mosharov E., Dietrich P., Quazi A.Z., Savalle M., Nemani V., Chaudhry F.A., Edwards R.H., Stefanis L., Sulzer D. Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J. Neurosci. 2006, 26:11915-11922.
46. Lavedan C. The synuclein family. Genome Res. 1998, 8:871-880.
47. Li W., Hoffman P.N., Stirling W., Price D.L., Lee M.K. Axonal transport of human alpha-synuclein slows with aging but is not affected by familial Parkinson's disease-linked mutations. J. Neurochem. 2004, 88:401-410.
48. Liu S., Fa M., Ninan I., Trinchese F., Dauer W., Arancio O. Alpha-synuclein involvement in hippocampal synaptic plasticity: role of NO, cGMP, cGK and CaMKII. Eur. J. Neurosci. 2007, 25:3583-3596.
49. Liu D., Jin L., Wang H., Zhao H., Zhao C., Duan C., Lu L., Wu B., Yu S., Chan P., Li Y., Yang H. Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells. Neurochem. Res. 2008, 33:1401-1409.
50. Liu S., Ninan I., Antonova I., Battaglia F., Trinchese F., Narasanna A., Kolodilov N., Dauer W., Hawkins R.D., Arancio O. alpha-Synuclein produces a long-lasting increase in neurotransmitter release. EMBO J. 2004, 23:4506-4516.
51. Lotharius J., Barg S., Wiekop P., Lundberg C., Raymon H.K., Brundin P. Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem. 2002, 277:38884-38894.
52. Lou H., Montoya S.E., Alerte T.N., Wang J., Wu J., Peng X., Hong C.S., Friedrich E.E., Mader S.A., Pedersen C.J., Marcus B.S., McCormack A.L., Di Monte D.A., Daubner S.C., Perez R.G. Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J. Biol. Chem. 2010, 285:17648-17661.
53. Martí M.J., Tolosa E., Campdelacreu J. Clinical overview of the synucleinopathies. Mov. Disord. 2003, 18:21-27.
54. Martin S.J., Grimwood P.D., Morris R.G. Synaptic plasticity and memory: an evaluation of the hypothesis. Annu. Rev. Neurosci. 2000, 23:649-711.
55. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A., Mucke L. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000, 287:1265-1269.
56. Murphy D.D., Rueter S.M., Trojanowski J.Q., Lee V.M. Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. J. Neurosci. 2000, 20:3214-3220.
57. Nakashima-Yasuda H., Uryu K., Robinson J., Xie S.X., Hurtig H., Duda J.E., Arnold S.E., Siderowf A., Grossman M., Leverenz J.B., Woltjer R., Lopez O.L., Hamilton R., Tsuang D.W., Galasko D., Masliah E., Kaye J., Clark C.M., Montine T.J., Lee V.M., Trojanowski J.Q. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol. 2007, 114:221-229.
58. Nemani V.M., Lu W., Berge V., Nakamura K., Onoa B., Lee M.K., Chaudhry F.A., Nicoll R.A., Edwards R.H. Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 2010, 65:66-79.
59. Nielsen M.S., Vorum H., Lindersson E., Jensen P.H. Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 2001, 276:22680-22684.
60. Parsons S.M. Transport mechanisms in acetylcholine and monoamine storage. FASEB J. 2000, 14:2423-2434.
61. Peng X., Tehranian R., Dietrich P., Stefanis L., Perez R.G. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J. Cell Sci. 2005, 118:3523-3530.
62. Perez R.G., Waymire J.C., Lin E., Liu J.J., Guo F., Zigmond M.J. A role for alpha-synuclein in the regulation of dopamine biosynthesis. J. Neurosci. 2002, 22:3090-3099.
63. Perrin R.J., Woods W.S., Clayton D.F., George J.M. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis. J. Biol. Chem. 2000, 275:34393-34398.
64. Recchia A., Debetto P., Negro A., Guidolin D., Skaper S.D., Giusti P. Alpha-synuclein and Parkinson's disease. FASEB J. 2004, 18:617-626.
65. Segrest J.P., De Loof H., Dohlman J.G., Brouillette C.G., Anantharamaiah G.M. Amphipathic helix motif: classes and properties. Proteins 1990, 8:103-117.
66. Sidhu A., Wersinger C., Vernier P. Does alpha-synuclein modulate dopaminergic synaptic content and tone at the synapse?. FASEB J. 2004, 18:637-647.
67. Sode K., Ochiai S., Kobayashi N., Usuzaka E. Effect of reparation of repeat sequences in the human alpha-synuclein on fibrillation ability. Int. J. Biol. Sci. 2006, 3:1-7.
68. Souza J.M., Giasson B.I., Chen Q., Lee V.M., Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J. Biol. Chem. 2000, 275:18344-18349.
69. Spillantini M.G., Crowther R.A., Jakes R., Cairns N.J., Lantos P.L., Goedert M. Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. Neurosci. Lett. 1998, 25:205-208.
70. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
71. Steidl J.V., Gomez-Isla T., Mariash A., Ashe K.H., Boland L.M. Altered short-term hippocampal synaptic plasticity in mutant alpha-synuclein transgenic mice. Neuroreport 2003, 14:219-223.
72. Tiraboschi P., Hansen L.A., Alford M., Sabbagh M.N., Schoos B., Masliah E., Thal L.J., Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology 2000, 54:407-411.
73. Tu P.H., Galvin J.E., Baba M., Giasson B., Tomita T., Leight S., Nakajo S., Iwatsubo T., Trojanowski J.Q., Lee VM-Y. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble a-synuclein. Ann. Neurol. 1998, 44:415-422.
74. Uéda K., Fukushima H., Masliah E., Xia Y., Iwai A., Yoshimoto M., Otero D.A., Kondo J., Ihara Y., Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:11282-11286.
75. Volles M.J., Lansbury P.T. Relationships between the sequence of alpha-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity. J. Mol. Biol. 2007, 366:1510-1522.
76. Watson J.B., Hatami A., David H., Masliah E., Roberts K., Evans C.E., Levine M.S. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein. Neuroscience 2009, 159:501-513.
77. Weihe E., Eiden L.E. Chemical neuroanatomy of the vesicular amine transporters. FASEB J. 2000, 14:2435-2449.
78. Wu B., Liu Q., Duan C., Li Y., Yu S., Chan P., Uéda K., Yang H. Phosphorylation of alpha-synuclein upregulates tyrosine hydroxylase activity in MN9D cells. Acta Histochem. 2009, (Epub ahead of print).
79. Yang M.L., Hasadsri L., Woods W.S., George J.M. Dynamic transport and localization of alpha-synuclein in primary hippocampal neurons. Mol. Neurodegener. 2010, 5:9.
80. Yavich L., Jäkälä P., Tanila H. Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J. Neurochem. 2006, 99:724-732.
81. Yavich L., Tanila H., Vepsäläinen S., Jäkälä P. Role of alpha-synuclein in presynaptic dopamine recruitment. J. Neurosci. 2004, 24:11165-11170.
82. Yu S., Li X., Liu G., Han J., Zhang C., Li Y., Xu S., Liu C., Gao Y., Yang H., Uéda K., Chan P. Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody. Neuroscience 2007, 145:539-555.
83. Yu S., Uéda K., Chan P. α-Synuclein and dopamine metabolism. Mol. Neurobiol. 2005, 31:243-254.
84. Yu S., Zuo X., Li Y., Zhang C., Zhou M., Zhang Y.A., Uéda K., Chan P. Inhibition of tyrosine hydroxylase expression in alpha-synuclein-transfected dopaminergic neuronal cells. Neurosci. Lett. 2004, 367:34-39.